Barrett's Esophagus is a change in the lining of your esophagus, the tube that carries food from your throat to your stomach. It happens because of long-term acid reflux, which is when stomach acid backs up into your esophagus. The lining changes from its normal flat cells to thicker, column-like cells that are similar to those found in your intestine or stomach. This change is a sign of severe reflux and can increase the risk of cancer.
Every report comes from a Lived member, sent anonymously.
Have you tried Prilosec (Omeprazole) for Barrett's Esophagus?
Barrett's esophagus is a change in the lining of the esophagus, the tube that carries food from the mouth to the stomach. After long exposure to stomach contents washing back up (reflux), the normal lining near the bottom of the esophagus can be replaced by tissue that resembles the lining of the intestine. The changed tissue does not cause symptoms by itself. Many people with Barrett's have heartburn or regurgitation, but those come from the reflux that usually accompanies it. Barrett's matters because it is the only known starting point for esophageal adenocarcinoma, a type of esophageal cancer. Most people with Barrett's esophagus never develop that cancer, and the aim of care is to find the uncommon cell changes that come before it while they can still be treated through an endoscope.
Researchers don't know exactly why some people with reflux develop Barrett's esophagus and others don't. Long-standing gastroesophageal reflux disease (GERD), meaning frequent reflux that irritates the esophagus, is the main recognized contributor. Only a small share of people with reflux have Barrett's: in one large analysis, about 2 in 100 people with reflux alone had it, and about 12 in 100 when reflux came with one other risk factor. Other factors make it more likely: being male, being White, being over 50, using tobacco, carrying excess weight around the waist, and having a parent, sibling or child with Barrett's esophagus or esophageal cancer. These are risk factors rather than causes. Many people with several of them never develop Barrett's, and a smaller number find it without ever having noticeable reflux.
Barrett's esophagus is diagnosed with an upper endoscopy, in which a thin, flexible tube with a camera is passed through the mouth to look at the lining of the esophagus. Because the changed tissue can be patchy, the doctor takes several small tissue samples (biopsies) from different areas; you don't feel them. A pathologist then looks for intestine-like cells under a microscope. US guidelines require the changed lining to extend at least 1 centimeter up the esophagus before calling it Barrett's. The biopsies also show whether there is dysplasia, meaning cells that look abnormal and may be heading toward cancer. It is reported as none, low grade or high grade, or as indefinite when inflammation makes it hard to judge. Pathologists often disagree about dysplasia, so guidelines recommend that any dysplasia result be confirmed by a second pathologist with expertise in digestive disease before it drives treatment. Testing for Barrett's is generally suggested for people who have had reflux symptoms at least weekly for five years or more and have three or more of the other risk factors. In that group, a swallowed capsule on a string is an accepted alternative first test: the capsule releases a small sponge or balloon that collects cells as it is pulled back out, and a positive result leads to endoscopy. If the esophagus is badly inflamed at the first endoscopy, the exam is usually repeated after 8 to 12 weeks of acid-reducing treatment, because Barrett's tissue can be missed until the inflammation heals.
Treatment depends mainly on whether the biopsies show dysplasia. For everyone, the foundation is controlling reflux. Guidelines suggest a proton pump inhibitor (PPI), a medicine that strongly reduces stomach acid, at least once a day; examples include omeprazole (Prilosec) and esomeprazole (Nexium). PPIs relieve heartburn and help an irritated esophagus heal, and observational studies link them with a lower chance of progressing toward cancer, although that evidence is not certain. Feeling better does not prove that acid is fully suppressed. Even so, guidelines do not raise the dose for that reason alone; a higher dose is used when symptoms are not controlled. PPIs are generally considered safe, and questions about long-term use are best reviewed with a clinician rather than settled by stopping the medicine. Habits that reduce reflux, such as not smoking, limiting alcohol, eating smaller meals, not eating close to bedtime, raising the head of the bed and reaching a healthier weight, help with symptoms. Surgery to tighten the valve between the esophagus and stomach can control reflux for some people, but it is not recommended as a way to prevent cancer. Without dysplasia, the usual plan is reflux treatment plus periodic endoscopy, called surveillance. When high-grade dysplasia or a very early cancer is found, it is treated through the endoscope: any visible raised area is cut out (endoscopic resection), and the remaining Barrett's lining is destroyed with heat (radiofrequency ablation) or extreme cold (cryotherapy). Confirmed low-grade dysplasia can be treated the same way or watched with closer surveillance, a choice made with the specialist. For early disease, these treatments give survival similar to removing the esophagus, with fewer complications. The most common complication is narrowing of the esophagus (a stricture), in about 1 in 20 people treated; bleeding and perforation (a tear through the wall) are much less common. Abnormal tissue can return, so endoscopies continue afterward. Surgery to remove part of the esophagus (esophagectomy) is now much less common and is not an option for everyone.
For most people, Barrett's esophagus is a long-term finding that never becomes cancer. Daily life is shaped mostly by managing reflux: taking an acid-reducing medicine regularly and keeping the habits that limit heartburn. The main ongoing commitment is surveillance endoscopy. Without dysplasia, US guidelines suggest repeating it about every 5 years when the Barrett's segment is shorter than 3 centimeters and every 3 years when it is longer. Dysplasia leads to closer checks or treatment, and after ablation, follow-up endoscopies continue on a schedule set by how advanced the cells were beforehand. The evidence that surveillance saves lives comes from observational studies and is weak, but it is the standard way to catch changes early, when they can be treated without major surgery. As people get older or develop other serious illnesses, the balance shifts. Guidelines suggest discussing whether to stop surveillance around age 75 for most people, or earlier for someone who could no longer undergo treatment if a problem were found.
If you have had frequent heartburn or regurgitation for years, especially with the risk factors above, ask whether screening for Barrett's makes sense for you. If you already have Barrett's, keep your surveillance appointments and tell your care team if reflux symptoms break through your medicine. Contact your care team, without waiting for your next scheduled endoscopy, if you have trouble swallowing or food feels stuck, lose weight without trying, or have vomiting that keeps recurring. Vomiting blood or material that looks like coffee grounds, or passing black, tarry stools, are signs of bleeding in the digestive tract and need medical help right away. If bleeding comes with fainting, confusion or a racing heart, get emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
I am just wondering what to expect from this recent diagnosis from anyone who has dealt with it